Cerebrospinal Fluid, Imaging, and Physiological Biomarkers in Dementia With Lewy Bodies

被引:9
|
作者
Mavroudis, Ioannis [1 ]
Petridis, Foivos [2 ]
Kazis, Dimitrios [2 ]
机构
[1] Leeds Teaching Hosp, Dept Neurol, Leeds LS9 7TF, W Yorkshire, England
[2] Aristotle Univ Thessaloniki, Dept Neurol 3, Thessaloniki, Greece
关键词
dementia with Lewy bodies; biomarkers; CSF; physiological; neuroimaging; PARKINSONS-DISEASE DEMENTIA; POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; ALPHA-SYNUCLEIN LEVELS; TEMPORAL-LOBE ATROPHY; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; DIFFERENTIAL-DIAGNOSIS; I-123-FP-CIT SPECT;
D O I
10.1177/1533317519869700
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Dementia with Lewy bodies is a progressive neurodegenerative disorder, clinically characterized by gradual cognitive impairment and fluctuating cognition, behavioral changes and recurrent visual hallucinations, and autonomic function and movement symptoms in the type of parkinsonism. It is the second most common type of dementia in the Western world after Alzheimer disease. Over the last 20 years, many neurophysiological, neuroimaging, and cerebrospinal fluid (CSF) biomarkers have been described toward a better discrimination between dementia with Lewy bodies, Alzheimer disease, and other neurodegenerative conditions.In the present review, we aim to describe the neurophysiological, imaging, and CSF biomarkers in dementia with Lewy bodies and to question whether they could be reliable tools for the clinical practice.
引用
收藏
页码:421 / 432
页数:12
相关论文
共 50 条
  • [41] Cerebrospinal fluid and plasma concentrations of nitric oxide metabolites are increased in dementia with Lewy bodies
    Molina, JA
    Leza, JC
    Ortiz, S
    Moro, MA
    Pérez, S
    Lizasoaín, I
    Urigüen, L
    Oliva, JM
    Manzanares, J
    NEUROSCIENCE LETTERS, 2002, 333 (02) : 151 - 153
  • [42] Imaging in Dementia With Lewy Bodies: An Overview
    Watson, Rosie
    Colloby, Sean J.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2016, 29 (05) : 254 - 260
  • [43] Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage
    Bousiges, Olivier
    Bombois, Stephanie
    Schraen, Susanna
    Wallon, David
    Quillard, Muriel Muraine
    Gabelle, Audrey
    Lehmann, Sylvain
    Paquet, Claire
    Amar-Bouaziz, Elodie
    Magnin, Eloi
    Miguet-Alfonsi, Carole
    Delbeuck, Xavier
    Lavaux, Thomas
    Anthony, Pierre
    Philippi, Nathalie
    Blanc, Frederic
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (05): : 467 - 475
  • [44] Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer's Disease and Dementia with Lewy Bodies
    Longobardi, Antonio
    Nicsanu, Roland
    Bellini, Sonia
    Squitti, Rosanna
    Catania, Marcella
    Tiraboschi, Pietro
    Saraceno, Claudia
    Ferrari, Clarissa
    Zanardini, Roberta
    Binetti, Giuliano
    Di Fede, Giuseppe
    Benussi, Luisa
    Ghidoni, Roberta
    CELLS, 2022, 11 (03)
  • [45] Amyloid Pathology Influences Aβ1-42 Cerebrospinal Fluid Levels in Dementia with Lewy Bodies
    Slaets, Sylvie
    Le Bastard, Nathalie
    Theuns, Jessie
    Sleegers, Kristel
    Verstraeten, Aline
    De Leenheir, Evelyn
    Luyckx, Jill
    Martin, Jean-Jacques
    Van Broeckhoven, Christine
    Engelborghs, Sebastiaan
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (01) : 137 - 146
  • [46] Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies
    Perra, Daniela
    Bongianni, Matilde
    Novi, Giovanni
    Janes, Francesco
    Bessi, Valentina
    Capaldi, Stefano
    Sacchetto, Luca
    Tagliapietra, Matteo
    Schenone, Guido
    Morbelli, Silvia
    Fiorini, Michele
    Cattaruzza, Tatiana
    Mazzon, Giulia
    Orru, Christina D.
    Catalan, Mauro
    Polverino, Paola
    Bernardini, Andrea
    Pellitteri, Gaia
    Valente, Mariarosa
    Bertolotti, Claudio
    Nacmias, Benedetta
    Maggiore, Giandomenico
    Cavallaro, Tiziana
    Manganotti, Paolo
    Gigli, Gianluigi
    Monaco, Salvatore
    Nobili, Flavio
    Zanusso, Gianluigi
    BRAIN COMMUNICATIONS, 2021, 3 (02)
  • [47] Serum peptides as candidate biomarkers for dementia with Lewy bodies
    Suzuki, Itsuku
    Noguchi, Miwa
    Arito, Mitsumi
    Sato, Toshiyuki
    Omoteyama, Kazuki
    Maedomari, Mioto
    Hasegawa, Hiroshi
    Suematsu, Naoya
    Okamoto, Kazuki
    Kato, Tomohiro
    Yamaguchi, Noboru
    Kurokawa, Manae S.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (12) : 1195 - 1206
  • [48] In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies
    Paraskevas, George P.
    Bougea, Anastasia
    Constantinides, Vasilios C.
    Bourbouli, Mara
    Petropoulou, Olga
    Kapaki, Elisabeth
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2019, 47 (4-6) : 289 - 296
  • [49] Biomarkers of Parkinson's disease and Dementia with Lewy bodies
    Henchcliffe, Claire
    Dodel, Richard
    Beal, M. Flint
    PROGRESS IN NEUROBIOLOGY, 2011, 95 (04) : 601 - 613
  • [50] From protein biomarkers to proteomics in dementia with Lewy Bodies
    Tsamourgelis, Augoustos
    Swann, Peter
    Chouliaras, Leonidas
    O'Brien, John T.
    AGEING RESEARCH REVIEWS, 2023, 83